Neurology, Neuromuscular Disease
-
People
-
Primary Appointments
- Bedlack, Richard Stanley, Professor of Neurology
- Gable, Karissa Lorraine, Assistant Professor of Neurology
- Gonzalez, Natalia Laura, Medical Instructor in the Department of Neurology
- Guptill, Jeffrey, Associate Professor of Neurology
- Hobson-Webb, Lisa Deneen, Associate Professor of Neurology
- Juel, Vern Charles, Professor of Neurology
- Massey, Janice Munn, Professor of Neurology
- Raja, Shruti Mukund, Assistant Professor of Neurology
- Sanders, Donald Benjamin, Professor of Neurology
-
-
Administers Grant
- 3,4,-Diaminopyridine In Lambert-Eaton Myasthenic Syndrome
- 3,4-Diaminopyridine In Lambert-Eaton Myasthenic Syndrome
- 3,4-Diaminopyridine In Lambert-Eaton Syndrome
- A Phase 3, Open-Label, Multi-Center Trial to Evaluate the Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in
- A trial of mycophenolate mofetil in Myasthenia Gravis
- AANEM Autoimmune Neuromuscular Disorders Fellowship
- ALXN1210-MG-306
- ASPEN-1 Single treatment Daxibotulinum Toxin A
- Acetylcholine receptor binding B cells as biomarker for myasthenia gravis
- Collaborative Agreement between Duke University and True North Therapeutics, Inc.
- ECU-MG-301 in Myasthenia Gravis pts. Open Label
- Eculizumab in Subjects with Generalized Refractory Myasthenia Gravis (GMG)
- Electrical Impedance Myography and Muscle Ultrasound: Longitudinal Measures in Pompe Disease
- Exploratory Study of BioMarkers lPredicting Response to Immunosuppressives in MG
- Grifols GTI1306
- Grifols GTI1408
- High Impact Pilot Project on Myasthenia Gravis and Related Neuromuscular Junction Disorders
- Immunologic Changes in the Treatment of Myasthenia Gravis
- Immunologic Studies in Myasthenia Gravis
- Mechanisms of Immune Dysregulation in Chronic Inflammatory Demyelinating Polyneuropathy
- PCORI Study Investigator Meeting
- Pathogenic Th17 cell pathology in CIDP
- Promise MG
- Role of CD4 T Cell subsets as drivers of MG Diseases -
- Serimmune/Duke Collaboration (II)
- The PATH Study
- UCB UCB7665 in Mod to severe MG
- Vamorolone-2B DMD